The decrease in secreted RANKL levels results in decreased pAKT levels in the co-cultured breast cancer cells and, consequently, in decreased breast cancer cell migration in vitro and bone resorption in vivo [79]. This evidence concerns the gene TNFSF11 and breast cancer.